Search results
Results from the WOW.Com Content Network
The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark, is up 9% this year compared to 28% for the S&P 500. Will that trend continue in ...
The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. Learn more » *Stock Advisor returns as of January 21, 2025. Adria Cimino has no position in any of the stocks ...
The Best Biotech Stock to Invest $1,000 in Right Now. Alex Carchidi, The Motley Fool. June 18, 2024 at 7:50 AM. Viking ... 5 popular destinations travel planners won't be visiting this year. News.
In the third quarter, the company's revenue of $2.77 billion increased by 12% year over year, a strong performance for a biotech giant. The company's best CF treatment yet, Trikafta, accounted for ...
With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an impressive resume already, but it's just getting started. It's currently in the ...
In the second quarter, the company's top line soared by 39% year over year to $362.9 million. The biotech turned an adjusted net loss of $1.01 in the second quarter of 2023 into an adjusted net ...
Through the first six months of 2024, HIV sales rose by just 3% year over year to $9.1 billion. ... a little this year, the biotech stock trades at a lowly 12 times its estimated future profits ...
Of course, the best investments for beginners also offer tons of options for all kinds of investors. Here are some of the best health care ETFs based on their sub-sectors. (Data as of Aug. 6, 2024.)